ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO0705

Genetic Contributions, Phenotypic Characteristics, and Follow-Up Outcomes in Patients with Non-Neurogenic Neurogenic Bladder

Session Information

Category: Pediatric Nephrology

  • 1900 Pediatric Nephrology

Author

  • Tseng, Min-hua, Linkou Chang Gung Memorial Hospital, Taoyuan, Taoyuan City, Taiwan
Background

Non-neurogenic neurogenic bladder (NNNB) represents a significant clinical challenge in children. This study investigated the clinical characteristics, urodynamic findings, genetic background, and management outcomes in Taiwanese patients with NNNB.

Methods

We analyzed 11 patients (6 females, 5 males) with NNNB from multiple Taiwanese medical centers. Evaluations included renal function assessment, urinary tract imaging, voiding cystourethrography, uroflowmetry, and genetic analysis.

Results

Median age 8 years (2-18). Underlying conditions: motility bowel disease, megacolon, prune-belly syndrome, intractable constipation; 2 with colostomy. Initial eGFR 44-102 ml/min/1.73m2. Common findings: bladder wall thickening (6/11), emptying disorders (5/11), hydronephrosis (3/11). Vesicoureteral reflux in 4 patients (grades 1-4). Abnormal voiding in 8 patients; max flow 6.1-28 ml/sec. Genetic mutations in 7 (64%): ACTG2 (3), CHRNA3 (2), TP63, LRIG2. Management: spontaneous voiding (7), intermittent catheterization (3), indwelling catheter (1). UTI frequency: never to every 2-3 months. Over 5.5 years, two-thirds developed hydroureteronephrosis; 3 reached advanced CKD (2 stage IV, 1 stage V)

Conclusion

Our study demonstrates significant clinical heterogeneity in NNNB with identifiable genetic mutations in approximately two-thirds of cases. ACTG2 and CHRNA3 mutations were most common, associated with severe bladder dysfunction and gastrointestinal motility disorders. These findings suggest important genotype-phenotype correlations that may guide personalized management approaches and genetic counseling.

Digital Object Identifier (DOI)